Sofosbuvir/Velpatasvir is a fixed dose combination medication for the treatment of hepatitis C. It combines Sofosbuvir 400mg and Velpatasvir 100mg. It is more than 90% effective for hepatitis C genotypes one through six
Sofosbuvir-Velpatasvir is the first available Pangenotypic NS5A-NS5B inhibitor single-pill combination regimen, and is highly efficacious across HCV genotypes 1 to 6. It provides a much-needed interferon-free option for patients with genotype 3 infection that is more economical than Sofosbuvir plus Daclatasvir, and in patients who have compensated cirrhosis with genotype 3, this single-pill option provides an important Ribavirin-free combination.
Product Details:
Minimum Order Quantity | 3 Pack |
Composition | VELPATASVIR / SOFOSBUVIR |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Manufacturer | NATCO PHARMA LTD |
Packaging Size | 28 Tablets |
Packaging Type | Box |
Strength | Velpatasvir 100mg & Sofosbuvir 400 mg |
Form | Tablets |
Shelf life | 2 Years |
Brand | Velpanat |
Manufacture By | NATCO PHARMA LTD |
Product Details:
Minimum Order Quantity | 3 Pack |
Packaging Size | 28 Tablets |
Packaging Type | Box |
Strength | Velpatasvir 100mg & Sofosbuvir 400 mg |
Form | Tablets |
Brand | Velasof |
Manufacture By | Hetero |